BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 News By Date

SuMoTuWeThFrSa
2829301234
567891011
12131415161718
19202122232425
2627282930311
2345678

 Wednesday, October 01, 2014
 Top Breaking News
Allergan Inc. (AGN) Quietly Leases A 90,000 Square Feet Space In Texas
Boehringer Ingelheim Corporation To Create 100 New Jobs With $125 Million+ Site Expansion
FDA Slaps Valeant (VRX) With A Warning Letter
Bristol-Myers Squibb Company (BMY) Sheds $1.4B In Pension Liabilities By Transferring Risk To Prudential
Novartis AG (NVS) Ditches Hepatitis C Drug Dreams, Breaks $440 Million Enanta Pharmaceuticals, Inc. Deal
SF Biotech FibroGen, Inc. Plots $125 Million IPO As It Muscles Its Way Into Fibrosis
Novartis AG (NVS) To Roll Out 15 Abstracts At EADV
Endocyte, Inc. (ECYT) Faces Big Decisions On Cancer Drug Vintafolide
Akorn, Inc. (AKN) Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution
After Snagging 18 Products From AstraZeneca PLC (AZN), IGI Laboratories, Inc. Grabs Two More From Valeant (VRX)
Portola Pharmaceuticals, Inc.'s ANNEXA™ Reverses Effect Of Anti-Clotting Drugs In Phase 3 Study
Abstracts For Merck & Co. (MRK), Gilead Sciences, Inc. (GILD) And AbbVie (ABBV) Look Promising, Says ISI
Ardelyx Inc. (ARDX) Looks Good After Tenanpanor Results: Citi Analysts
Oncore Grabs Enantigen Therapeutics For Undisclosed Amount
Ardelyx Inc. (ARDX) Irritable Bowel Syndrome Drug Succeeds In Phase 2b Trial
Islet Sciences, BHV Pharma, Inc. Merges; Combined Company To Be Named Avogenx
GE Corporation (GE), University of California, San Francisco (UCSF), Agencies Partner Up To Define, Attack Traumatic Brain Injuries
Alimera Sciences (ALIM) Receives $25 Million Advance From Hercules Technology Growth Capital
Novartis AG (NVS) Must Face U.S. Lawsuit Over Doctor Kickbacks
Celgene (CELG) And Sanofi (France) (SAN.PA) CEOs Among Headliners For Exclusive Forbes Event
Drugmakers, Medtechs Paid $3.5 Billion To Doctors And Leading Hospitals
New £26 Million Medical Research Centre Unveiled In Dundee
Retrophin, Inc. (RTRX) Announces Leadership Reorganization
Lucideon (Formerly Known As CERAM) To Create 100 New Jobs and Bolster U.S. Presence in Innovation Push
 Featured Stories
 More News
Diplomat Release: XTANDI® (enzalutamide) Receives Expanded Approval From FDA For Treatment Of Metastatic Castration-Resistant Prostate Cancer
Mesoblast Limited (MSB.AX) Partner JCR Pharmaceuticals Files For Marketing Approval Of The First Allogeneic Stem Cell Product In Japan
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Submit European Marketing Authorization Application For Migraine Drug RIZAPORT® (Formerly RHB-103)
Zogenix, Inc. (ZGNX) Submits Modified Formulation Of Zohydro® ER With Potential Abuse Deterrent Properties For FDA Review
XOMA (US) LLC (XOMA) Initiates U.S. Clinical Trial Of Gevokizumab In Patients With Behcet's Disease Uveitis - EYEGUARD™-U.S.
Zafgen (ZFGN) Announces Initiation Of Phase 3 Trial Of Beloranib In Prader-Willi Syndrome
ERYtech Pharma Reports Positive Top-Line Phase III Results From Clinical Study With GRASPA® In Acute Lymphoblastic Leukemia
Alnylam Pharmaceuticals (ALNY) Initiates EXPLORE, A Prospective Observational Study Of Patients With Hepatic Porphyrias
Innate Pharma (IPH.PA ) : Initiation Of A Phase I Clinical Trial Of Lirilumab In Combination With Elotuzumab
Compugen Ltd. (CGEN) Discloses New Results For Novel Target Candidate For Cancer Immunotherapy
Albert Einstein College of Medicine Release: Comprehensive Study Of Allergic Deaths In U.S. Finds Medications Are Main Culprit
WuXi PharmaTech Co., Ltd. Laboratory Testing Division Expands In U.S. With Acquisition Of XenoBiotic Laboratories, Inc.
Harvard Bioscience Inc. (HBIO) Acquires Multi Channel Systems MCS GmbH And Triangle BioSystems, Inc.
Recipharm AB Completes Acquisition Of Corvette Pharmaceutical Services Group For SEK1.1 Billion
Merck & Co. (MRK) Completes Sale Of Consumer Care Business To Bayer AG (BAYZF) For $14.2 Billion
Swiss Foundation For People With Rare Diseases Combines GENALICE And Knome Solutions To Improve DNA Analysis
Isis Pharmaceuticals, Inc. (ISIS) Earns $1.5 Million From GlaxoSmithKline (GSK) For The Advancement Of ISIS-GSK4 Rx
Open Monoclonal Technology, Inc. Grants Unlimited OmniRat, OmniMouse And OmniFlic License
Clinical Conductor CTMS And OpenClinica EDC Form First Of Its Kind Partnership
Karmanos Cancer Institute, Wayne State University Enhance Commitment To Cancer Care, Research
Bitplane Brings Voloom To The Wider Life Sciences Market
Dyadic International, Inc. Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes
Abaxis, Inc. (ABAX) Announces Distribution Agreement With Patterson Veterinary Supply
Northwestern University Joins $20 Million National Uterine Fibroid Study
Protein Metrics Licenses Lipid Analysis Software From Pacific Northwest National Laboratories
Texas Children's Hospital And Baylor College of Medicine Receives Grant To Help Determine Best Care Practices For Children With Spina Bifida
Curtana Pharmaceuticals Awarded National Institutes of Health (NIH) Small Business Technology Transfer Grant To Advance Glioblastoma Cancer Therapy
Discovery Laboratories (DSCO) Receives SBIR Grant Valued Up To $3.0 Million To Support Development Of Aerosolized KL4 Surfactant To Address Radiation-Induced Lung Injury
Stemedica Cell Technologies, Inc. Secures U.S. Patent To Use Multiple Stem Cell Lines Simultaneously To Treat Ischemic Stroke
Prollenium Medical Technologies Release: Lyracaine Topical Anesthetic Now Approved For Sale In Canada
Ranbaxy Laboratories (RANBAXY.BO) Launches ABSORICA® (isotretinoin) 25 Mg And 35 Mg Capsules In The U.S. Market
TherapeuticsMD, Inc.  (TXMD) Granted Two New Patents
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Ferric Citrate Covering Orally Administrable Forms
Assembly Biosciences Announces $15.75 Million Registered Direct Offering
Perrigo Company (PRGO) Announces Extension Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043
Otonomy, Inc. (OTIC) Added To Russell 2000® Index
VBL Therapeutics (VBLX) Announces Pricing Of Initial Public Offering
Vital Therapies, Inc. (VTI) (VTL) Announces Launch Of Proposed Follow-On Offering
Conversion Right Triggered for Laboratory Corporation of America Holdings (LabCorp) (LH)’s Zero Coupon Convertible Subordinated Notes Due 2021
H&Q Life Sciences Investors Pays Stock Distribution
AMATSIGROUP Expands Operations Into The USA
Multiple Myeloma Research Consortium Hits All Time Record-Opens Six New Clinical Trials In 2014
NanoViricides, Inc. (NNVC.PK) Reports Flucide™ Samples Were Shipped To Basi For Start Of Safety/Toxicology Studies; Also Reports That Ebola Drug Candidates Are Being Synthesized
BrainStorm Cell Therapeutics Inc. Completes Uplisting To The NASDAQ Capital Market
New SLE And SPE Automation System From Biotage AB (BIOTa.ST) - Flexible, Simple And Reliable
Cardio3 BioSciences Announces New Business Development Strategy To Broaden Its Product Pipeline
Sophia Genetics Launches Full CFTR Analysis In Single Clinical Grade NGS Experiment
Eurofins Genomics Extends Its Genomic Business In Italy
Cyprotex (COTXF.PK) Expansion Of Toxicology Capabilities
IDEXX Laboratories, Inc. (IDXX) Announces Several Milestones In Its US All-Direct CAG Distribution Strategy
Pfanstiehl Laboratories Launches Cgmp-Produced Mannose For Cell Culture Media Optimization & Glycoprotein Biosynthesis
ChromaDex, Inc. Release: Life Extension Introduces A New Anti-Aging Supplement, NAD+ Cell Regenerator™, Featuring NIAGEN™
Aerie Pharmaceuticals, Inc. (AERI) Announces Closing Of $125 Million Convertible Notes Financing
Spherix (SPEX) Release: Markman Hearing Date For Vtech And Uniden Litigation Now Set For November 10, 2014
Information Update - Health Canada Takes Action To Stop Import Of Products From Three Sites In India
Tokyo Electron Launches Its Open Innovation Stem Cell Technology Centre (STC) In The UK To Develop Smart Cell Processing Technologies
genae associates Opens Offices In New York City
BioNTech AG GANYMED Pharmaceuticals AG Open New Research Headquarters In Mainz, Germany
Reflect Scientific, Inc. Announces New Product For Low Temperature Biotech Shipping
Aoxing Pharmaceutical Company Inc. (AXN) Announces Financial Results For 2014 Fiscal Year
Abbott Laboratories (ABT) Hosts Conference Call For Third-Quarter Earnings
Becton, Dickinson and Company (BDX) Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
Bristol-Myers Squibb Company (BMY) To Announce Results For Third Quarter On October 24
Celgene (CELG) To Announce Third Quarter 2014 Results On October 23, 2014
Cellectis (ALCLS): First-Half 2014 Financial Results
Getinge Announces Date Of 2014 Q3 Report And Conference Call
IsoRay, Inc. (ISR) Reports Fiscal Year 2014 Results
NanoViricides, Inc. (NNVC.PK) Files Annual Report
PAREXEL International (PRXL) Announces Date Of First Quarter Fiscal Year 2015 Earnings Release And Conference Call
Pacific Biosciences (PACB) Third Quarter 2014 Financial Results Call
Thermo Fisher Scientific (TMO) To Hold Earnings Conference Call On Wednesday, October 22, 2014
LifeMap Solutions Adds Chief Technology Officer to Leadership Team
Nuvilex (NVLX) Announces Strategic Changes To Leadership Team And Appoints Prof. Dr. Walter H. Gunzburg As Chief Scientific Officer
IntelliPharmaCeutics Announces Resignation Of Chief Financial Officer
AuraSense Therapeutics Welcomes Key Personnel, Further Expanding Leadership Team
Audentes Therapeutics Announces Continued Expansion Of Senior Management Team
GB Sciences Names Business And Public Policy Expert As Special Advisor To The CEO
Juno Therapeutics Appoints Hal Barron, M.D. To Board Of Directors
NeoStem, Inc. Establishes Melanoma Scientific Advisory Board To Support Anticipated Phase 3 Trial
Macrocure (MCUR) Nominates Katherine Wolf And Yuval Yanai For Election To Board Of Directors And Announces Special General Meeting Of Shareholders
Gil Yosipovitch, M.D. Joins Trevi Therapeutics’ Clinical Advisory Board
Mettler-Toledo (MTD)’s XS Balance Line Delivers Performance And Ergonomics To Safeguard Health In The Workplace
Acceleron Pharma To Host Educational Webcast On Beta-thalassemia
Roka Bioscience, Inc. (ROKA) Release: GoEngineer's PLM Bridge Simplifies Agile PLM Integrations
Health Canada Release: Statement By The Honourable Rona Ambrose On The Import Ban Of Drug Products From Three Plants In India
Cancer Treatment Centers Of America At Midwestern Regional Medical Center Recognized For Exemplary Stem Cell Treatment And Cell Therapy Program
23andMe, Inc. Announces New Service For Canada
ResMed Inc. (RMD) Launches Initiative To Help Women Get Better Sleep
Novartis AG (NVS) Announces Skin Impressions Campaign Launch On The First International Urticaria Day, To Provide Support To People Living With Severe Skin Diseases Such As Chronic Idiopathic Urticaria (CIU)
Hologic, Inc. (HOLX) To Kick Off National Breast Cancer Awareness Month At The October 1 NASDAQ Stock Market Opening Bell Ceremony
Abbott Laboratories (ABT) Goes Extra Mile In Commitment To Helping People Live Healthy Lives As An Official Sponsor Of Bank of America (BAC) Chicago Marathon
Results Of Eisai Inc. (ESALF.PK) And Epilepsy Foundation National Survey Shed Light On Unmet Needs In Epilepsy Community
BioClinica, Inc. Compass™ Wins Technology Innovation Award
Genzyme Corporation (GENZ) Announces Winners Of Patient Advocacy Leadership (PAL) Awards
Baxter International, Inc. (BAX) Recognized By Healthcare Businesswomen’s Association With ACE Award For Its Baxter Women Leaders Business Resource Group
Epizyme (EPZM) Announces Clinical Data From Phase 1 Trial Of EZH2 Inhibitor EPZ-6438 (E7438) To Be Presented At EORTC-NCI-AACR Symposium
AbbVie (ABBV) Demonstrates Commitment To Continued Research In Hepatitis C With Investigational Data From Clinical Program Being Presented At The Liver Meeting®
BioJapan 2014 World Business Forum Exhibitor Profiles
ContraFect Corporation (CFRXU) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum
Acceleron Pharma To Host Educational Webcast On Beta-Thalassemia
Advaxis, Inc.'s Chief Scientific Officer, Dr. Robert Petit, Leads Panel Discussion On Combination Immunotherapies
Pressure BioSciences, Inc. (BBII) Invited To Present At The 2nd Global Life Sciences Conference In Warsaw, Poland
Columbia Laboratories, Inc. (CBRX)' UK Subsidiary To Launch New Development Platform At CPHI
Shionogi, Inc. Announces Four Abstracts To Be Presented At The 25th Annual Meeting Of The North American Menopause Society (NAMS) In Washington, DC
The Obesity Society Release: Latest In Weight Loss Strategies To Be Unveiled At Premier International Meeting For Obesity Science & Treatment
Tobira Therapeutics Inc.' Cenicriviroc Shows Improvement In Liver Fibrosis Scores In Phase 2b Study To Be Presented At AASLD
StemCells Inc. (STEM) To Participate At The 2014 Stem Cell Meeting On The Mesa
Genoscience Pharma Presents Data On Candidates Targeting Cancer Stem Cells At The 26th EORTC-NCI-AACR Symposium
Rebiotix Release: Results of Study Assessing Microbiota-Based Drug Targeted At Recurrent C. difficile Infection To Be Presented At ACG 2014
Inscopix Announces Doubling Of Its DECODE Grant Program At The White House BRAIN Conference
Apricus Biosciences (APRI) Biosciences To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum
Avalanche Biotechnologies (AAVL) To Participate In Gene Therapy Panel At The Biotechnology Industry Organization (BIO) Investor Forum
Argos Therapeutics, Inc. (ARGS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum
Zocere, Inc.’s Stroke Drug To Be Featured At Biotechnology Industry Organization (BIO) Investor Forum